Emmessar Biotech & Nutrition Ltd

Emmessar Biotech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Emmessar Biotech & Nutrition Ltd

₹ 48.0 -3.11%
14 Nov 12:12 p.m.
ebnl.org BSE: 524768
About

Incorporated in 1992, Emmessar Biotech & Nutrition Ltd is in the business of Healthcare, Fine Chemicals and Renting of Immovable property[1]

Key Points

Business Overview:[1]
EBNL is a global healthcare company that manufactures and markets healthcare & nutritional products. It fuses various concepts & principles (both ancient & modern) from Biophysics, Biochemistry, Biotechnology and the Indian system of medicine AYUSH (Ayurveda + Yoga + Unani + Siddha + Homeopathy) to create products. This integration resulted in technology called VedaCeuticals which forms the foundation of all products of EBNL

Website BSE
  • Market Cap ₹ 24.0 Cr.
  • Current Price ₹ 48.0
  • High / Low ₹ 64.0 / 23.3
  • Stock P/E 27.6
  • Book Value ₹ 15.6
  • Dividend Yield 0.00 %
  • ROCE 11.4 %
  • ROE 10.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 3.09 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -2.33% over past five years.
  • Company has a low return on equity of 8.92% over last 3 years.
  • Earnings include an other income of Rs.1.98 Cr.
  • Working capital days have increased from 81.8 days to 163 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
0.04 0.16 0.15 0.21 0.07 0.43 0.32 0.07 0.08 0.33 0.08 0.08 0.34
0.27 0.38 0.33 0.36 0.27 0.60 0.48 0.35 0.30 0.54 0.47 0.36 0.42
Operating Profit -0.23 -0.22 -0.18 -0.15 -0.20 -0.17 -0.16 -0.28 -0.22 -0.21 -0.39 -0.28 -0.08
OPM % -575.00% -137.50% -120.00% -71.43% -285.71% -39.53% -50.00% -400.00% -275.00% -63.64% -487.50% -350.00% -23.53%
0.43 0.41 0.71 0.44 0.43 0.44 0.42 0.46 0.53 0.53 0.48 0.46 0.51
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.02 0.02 0.04 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02
Profit before tax 0.18 0.17 0.49 0.27 0.21 0.25 0.24 0.16 0.29 0.30 0.07 0.16 0.41
Tax % 0.00% 0.00% 91.84% 25.93% 33.33% 108.00% 20.83% 68.75% 31.03% 56.67% -428.57% 43.75% 31.71%
0.18 0.17 0.03 0.20 0.13 -0.02 0.20 0.05 0.20 0.13 0.37 0.09 0.28
EPS in Rs 0.36 0.34 0.06 0.40 0.26 -0.04 0.40 0.10 0.40 0.26 0.74 0.18 0.56
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
0.58 1.37 2.19 1.98 2.61 1.27 0.63 3.40 6.99 0.36 1.02 0.56 0.83
0.77 1.43 2.34 2.66 2.38 1.67 1.27 3.81 6.15 1.26 1.71 1.64 1.79
Operating Profit -0.19 -0.06 -0.15 -0.68 0.23 -0.40 -0.64 -0.41 0.84 -0.90 -0.69 -1.08 -0.96
OPM % -32.76% -4.38% -6.85% -34.34% 8.81% -31.50% -101.59% -12.06% 12.02% -250.00% -67.65% -192.86% -115.66%
0.08 0.09 0.06 0.03 0.98 1.25 1.01 1.21 1.47 1.92 1.75 1.99 1.98
Interest 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.07 0.20 0.07 0.03 0.01 0.05 0.08 0.06 0.06 0.09 0.09 0.10 0.08
Profit before tax -0.18 -0.17 -0.16 -0.68 1.19 0.80 0.29 0.74 2.25 0.93 0.97 0.81 0.94
Tax % 0.00% 82.35% -25.00% -30.88% 0.00% -15.00% -82.76% -2.70% 36.00% 48.39% 47.42% 7.41%
-0.18 -0.31 -0.12 -0.47 1.19 0.91 0.53 0.75 1.45 0.48 0.50 0.75 0.87
EPS in Rs -0.36 -0.62 -0.24 -0.94 2.38 1.82 1.06 1.50 2.90 0.96 1.00 1.50 1.74
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -9%
5 Years: -2%
3 Years: -57%
TTM: -8%
Compounded Profit Growth
10 Years: 16%
5 Years: 0%
3 Years: -20%
TTM: 102%
Stock Price CAGR
10 Years: 19%
5 Years: 35%
3 Years: 24%
1 Year: 102%
Return on Equity
10 Years: 17%
5 Years: 15%
3 Years: 9%
Last Year: 11%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00
Reserves -3.04 -3.42 -3.62 -4.09 -2.91 -2.01 -1.49 -0.73 0.70 1.17 1.67 2.41 2.77
0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.00 0.00 0.00 0.08 0.11 0.00
2.97 0.65 1.03 1.36 1.13 0.92 1.59 1.86 2.11 1.04 1.19 1.23 1.52
Total Liabilities 4.93 2.23 2.41 2.27 3.22 3.91 5.17 6.13 7.81 7.21 7.94 8.75 9.29
1.84 1.58 1.42 0.73 0.72 2.25 1.99 1.91 1.86 2.07 2.00 1.91 1.86
CWIP 0.00 0.00 0.00 0.00 0.80 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
3.08 0.64 0.98 1.53 1.69 1.65 3.17 4.21 5.94 5.13 5.93 6.83 7.42
Total Assets 4.93 2.23 2.41 2.27 3.22 3.91 5.17 6.13 7.81 7.21 7.94 8.75 9.29

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-0.02 0.00 -0.01 0.75 0.74 0.39 1.03 0.47 2.27 0.38 0.64
-0.01 0.00 0.00 -0.74 -0.69 -0.37 -1.06 0.01 -2.61 -0.55 -0.64
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash Flow -0.03 0.00 -0.01 0.01 0.05 0.01 -0.03 0.48 -0.34 -0.17 0.00

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 1,686.55 45.29 6.67 66.36 5.59 8.62 23.17 3.22 141.51 10.14 3.58 13.04
Inventory Days 529.25 267.67 335.80 136.88 121.67 52.14 2,049.62 272.56 7.24 196.54 127.75 164.25
Days Payable 5,146.50 121.67 150.87 76.04 76.04 5.79 1,628.46 189.61 51.70 56.15 0.00 18.25
Cash Conversion Cycle -2,930.70 191.29 191.60 127.20 51.22 54.97 444.33 86.18 97.05 150.52 131.33 159.04
Working Capital Days 37.76 29.31 38.33 22.12 85.31 175.31 498.25 30.06 79.37 -60.83 143.14 162.95
ROCE % -8.78% -9.60% -10.81% -39.30% 80.00% 31.50% 17.66% 25.48% 45.14% 15.67% 15.02% 11.35%

Shareholding Pattern

Numbers in percentages

5 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
58.50% 58.50% 58.20% 58.20% 58.53% 59.08% 59.33% 59.53% 59.53% 59.53% 59.53% 59.53%
0.20% 0.20% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19%
41.31% 41.31% 41.61% 41.61% 41.27% 40.73% 40.46% 40.27% 40.28% 40.26% 40.27% 40.27%
No. of Shareholders 6,5526,9996,9706,9757,0246,9336,8746,8226,8447,1466,9006,936

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports